North America Bioactive Wound Management Market to 2027- COVID-19 Impact and Regional Analysis by Product; Application; End User, and Country

The North America bioactive wound management market is expected to reach US$ 1,333.21 million by 2027 from US$ 755.37 million in 2019. The market is estimated to grow at a CAGR of 7.4% during 2020-2027. The bioactive wound management market is growing primarily due to the increasing adoption of single-use bioactive wound management and rising demand of bioactive wound management by biopharmaceutical and biotechnology industry in the North America. Factors such as stringent regulatory frameworks are negatively impacting the growth of the market. Additionally, increasing research activities to introduce novel wound treatments and 3D printing in wound care management are likely to fuel the growth of the bioactive wound management market during the forecast period.

Bioactive wound care management is a new trend in the healthcare sector. These bioactive wound care products are produced from artificial and natural sources, which have a fewer chance of infection, and the healing process is faster; the risk of leaking is eliminated and eases pain and discomfort. The bioactive wound care products are cost and time effective. The materials in the bioactive wound dressings include hydrocolloids, alginates, chitosan, keratin, and collagen.

The rise in the incidence of chronic injuries and an increased number of surgical procedures are contributing to the growth of the market. The prevalence of surgical site infection is anticipated to rise owing to the growing number of surgeries. As per the Health Research Educational Trust (HRET), about 15.0 million surgeries are performed every year in the US, and approximately 2-5% of patients develop surgical site infections. Bioactive wound management products allow rapid healing of surgical site infection; the rising number of surgical procedures is anticipated to surge the demand for these products in the near future.

Moreover, the rising cases of injuries caused by traumatic events and road accidents are the major factors driving the market growth. For instance, as per the American Association for the Surgery of Trauma, road accidents kill 1.2 million people annually. Additionally, burn injuries are one of the major causes of developing chronic wounds. Road accidents, burn injuries, and other traumas have increased the number of surgeries. Such cases are expected to surge the demand for rapid wound healing products in the coming years.

The outbreak of the COVID-19 pandemic has adversely affected the non-healing or chronic wound management. COVID-19 among older people has resulted in severe complications and has accounted for a large number of deaths in the country. Additionally, chronic wounds or non-healing wounds are majorly seen in older people and takes a longer time to heal. Therefore, regular dressing and proper care is required to prevent chronic cases of infection and health condition. The outbreak of COVID-19 has impacted bioactive wound management market profoundly by affecting the quality care. It has not only affected wound care but also the entire healthcare system in the region.

In terms of product, the alginates accounted for the highest market share in 2019. The growth of this segment is attributed to the factors such as increasing need for efficient and cost-effective wound management, a wide range of products available in the market, and increasing adoption of bioactive treatment of chronic wounds. However, the bioengineered skin substitutes segment is expected to grow with the highest growth rate during the forecast period, owing to its acceptance in a wide range of chronic wounds due to its faster healing and reduced infection properties.

A few of the significant secondary sources associated with the North America bioactive wound management market report are the World Health Organization (WHO), U. S. National Institutes of Health (NIH), American Diabetes Association (ADA), American Podiatric Medical Association, American Burn Association, International Diabetes Federation, Health Research Educational Trust (HRET), American Association for the Surgery of Trauma, National Spinal Cord Injury Statistical Center, and among others.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Bioactive Wound Management market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the North America Bioactive Wound Management market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.